Unichem Laboratories informs about press release

16 Mar 2022 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed that it enclosed a press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem’s Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg.

The above information is a part of company’s filings submitted to BSE.

Unichem Lab Share Price

437.70 6.25 (1.45%)
31-Dec-2025 12:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.90
Dr. Reddys Lab 1267.85
Cipla 1502.00
Zydus Lifesciences 913.85
Lupin 2102.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×